52P Modified FOLFIRINOX versus CISGEM as first-line chemotherapy for advanced biliary tract cancer: Results of AMEBICA PRODIGE 38 randomized phase II trial.
Saved in:
| Title: | 52P Modified FOLFIRINOX versus CISGEM as first-line chemotherapy for advanced biliary tract cancer: Results of AMEBICA PRODIGE 38 randomized phase II trial. |
|---|---|
| Authors: | Phelip, J.M.1 (AUTHOR), Desrame, J.2 (AUTHOR), Edeline, J.3 (AUTHOR), Barbier, E.4 (AUTHOR), Terrebonne, E.5 (AUTHOR), Michel, P.6 (AUTHOR), Perrier, H.7 (AUTHOR), Dahan, L.8 (AUTHOR), Bourgeois, V.9 (AUTHOR), Khemissa Akouz, F.10 (AUTHOR), Soularue, E.11 (AUTHOR), Lebrun, V. Ly12 (AUTHOR), Molin, Y.13 (AUTHOR), Lecomte, T.14 (AUTHOR), Ghiringhelli, F.15 (AUTHOR), Coriat, R.16 (AUTHOR), Louafi, S.17 (AUTHOR), Neuzillet, C.18 (AUTHOR), Manfredi, S.19 (AUTHOR), Malka, D.20 (AUTHOR) |
| Source: | Annals of Oncology. 2020 Supplement 4, Vol. 31, pS260-S261. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 152694614 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 52P Modified FOLFIRINOX versus CISGEM as first-line chemotherapy for advanced biliary tract cancer: Results of AMEBICA PRODIGE 38 randomized phase II trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Phelip%2C+J%2EM%2E%22">Phelip, J.M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Desrame%2C+J%2E%22">Desrame, J.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Edeline%2C+J%2E%22">Edeline, J.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Barbier%2C+E%2E%22">Barbier, E.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Terrebonne%2C+E%2E%22">Terrebonne, E.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Michel%2C+P%2E%22">Michel, P.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Perrier%2C+H%2E%22">Perrier, H.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dahan%2C+L%2E%22">Dahan, L.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bourgeois%2C+V%2E%22">Bourgeois, V.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Khemissa+Akouz%2C+F%2E%22">Khemissa Akouz, F.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Soularue%2C+E%2E%22">Soularue, E.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lebrun%2C+V%2E+Ly%22">Lebrun, V. Ly</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Molin%2C+Y%2E%22">Molin, Y.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lecomte%2C+T%2E%22">Lecomte, T.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ghiringhelli%2C+F%2E%22">Ghiringhelli, F.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Coriat%2C+R%2E%22">Coriat, R.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Louafi%2C+S%2E%22">Louafi, S.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Neuzillet%2C+C%2E%22">Neuzillet, C.</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Manfredi%2C+S%2E%22">Manfredi, S.</searchLink><relatesTo>19</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Malka%2C+D%2E%22">Malka, D.</searchLink><relatesTo>20</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2020 Supplement 4, Vol. 31, pS260-S261. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152694614 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2020.08.030 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S260 Titles: – TitleFull: 52P Modified FOLFIRINOX versus CISGEM as first-line chemotherapy for advanced biliary tract cancer: Results of AMEBICA PRODIGE 38 randomized phase II trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Phelip, J.M. – PersonEntity: Name: NameFull: Desrame, J. – PersonEntity: Name: NameFull: Edeline, J. – PersonEntity: Name: NameFull: Barbier, E. – PersonEntity: Name: NameFull: Terrebonne, E. – PersonEntity: Name: NameFull: Michel, P. – PersonEntity: Name: NameFull: Perrier, H. – PersonEntity: Name: NameFull: Dahan, L. – PersonEntity: Name: NameFull: Bourgeois, V. – PersonEntity: Name: NameFull: Khemissa Akouz, F. – PersonEntity: Name: NameFull: Soularue, E. – PersonEntity: Name: NameFull: Lebrun, V. Ly – PersonEntity: Name: NameFull: Molin, Y. – PersonEntity: Name: NameFull: Lecomte, T. – PersonEntity: Name: NameFull: Ghiringhelli, F. – PersonEntity: Name: NameFull: Coriat, R. – PersonEntity: Name: NameFull: Louafi, S. – PersonEntity: Name: NameFull: Neuzillet, C. – PersonEntity: Name: NameFull: Manfredi, S. – PersonEntity: Name: NameFull: Malka, D. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2020 Supplement 4 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 31 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
